Trial Profile
An Open Multicentre Phase III Study to Investigate the Safety and Efficacy of Optivate in Children Under 6 Years of Age With Severe Haemophilia A.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Registrational; Therapeutic Use
- Sponsors Bio Products Laboratory
- 07 Oct 2014 New trial record